Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous immunoglobulin overtreatment in CIDP
2013-005363-52Phase 4Active
- Sponsor
- Amsterdam UMC, Department of Neurology
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of immune globulin in chronic inflammatory demyelinating polyneuropathy (CIDP) (2 arms), sponsored by Amsterdam UMC, Department of Neurology. Primary endpoint: Change in R-ODS score from baseline. Started Mar 2014; status: active.
02
Drugs
immune globulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2013-005363-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005363-52.